Reviews and feature articlesEosinophil responses during COVID-19 infections and coronavirus vaccination
Key words
Coronavirus
COVID-19
eosinophils
immunopathology
immunopotentiation
SARS
vaccines
Abbreviations used
COVID-19
Coronavirus disease 2019
RSV
Respiratory syncytial virus
S protein
Spike protein
SARS-CoV-1
Severe acute respiratory syndrome coronavirus 1
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
TLR
Toll-like receptor
Cited by (0)
Disclosure of potential conflict of interest: M. E. Rothenberg is a consultant for Pulm One, Spoon Guru, ClostraBio, Serpin Pharm, Celgene, Astra Zeneca, Allakos, Arena Pharmaceuticals, Guidepoint, Suvretta, and Capital Management; has an equity interest in the first 4 listed; receives royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust), and UpToDate; and is an inventor of patents owned by Cincinnati Children’s Hospital. The rest of the authors declare that they have no relevant conflicts of interest.
© 2020 American Academy of Allergy, Asthma & Immunology